Featured Stories
Inova’s Heart and Vascular Programs Receive $75 Million Gift from Dwight and Martha Schar
Institute will be renamed to Inova Schar Heart and Vascular; Schars offer challenge to Northern Virginia community Falls Church, VA – Today Inova announced a transformational gift from long-time supporters of Inova, Dwight and Martha Schar, to support the hospital system’s heart and vascular programs. The Schars’ gift of $75 million – one of the…
Read MoreNational Nurses Month: Celebrating Oncology Nurses
Anyone who has experienced a hospital stay or managed a chronic condition knows the impact nurses have on patients and their families. Not only do nurses deliver exceptional healthcare, but they also offer advocacy, support — and even friendship. During National Nurses Month each May, the American Nurses Association celebrates nurses who lead, excel…
Read MoreInova Expands Options for Treating Complex Aortic Disease
Inova uses a collaborative approach combining the expertise of different medical specialists with state-of-the-art technologies to offer patients access to leading-edge, less invasive, endovascular treatment options for complex aortic conditions. Cardiothoracic surgeons, vascular surgeons and interventional radiologists at Inova Heart and Vascular Institute (IHVI) work together to treat complex vascular diseases and conditions. They meet…
Read MoreNew Regional Medical Leadership Assures Consistency of Care at Inova
Inova Heart and Vascular Institute (IHVI) recently promoted four physicians to system-wide oversight roles, responsible for evaluating and overseeing safety, quality and efficiency to assure consistency in patient care. This change is part of IHVI’s continued efforts to improve and sustain positive outcomes for a growing number of cardiovascular patients. “Working closely with their counterparts…
Read MoreInova’s Involvement in Cardiology and Lung Disease Research Drives Care Improvements
Discovery and implementation of novel therapies through clinical research leads to improved patient care. The participation by Inova Heart and Vascular Institute (IHVI) in research furthers Inova’s commitment to excellence. Clinical research also allows patients to have access to leading-edge treatments and facilitates the identification of even more effective therapeutics for the future. Research areas…
Read MoreInova Experiences Significant Growth in Heart Transplants
Inova Heart and Vascular Institute (IHVI) is now the ninth busiest heart transplant center in the U.S. Even as the program’s volume has more than doubled over the past five years, clinical outcomes remain excellent compared to national benchmarks from the Scientific Registry of Transplant Recipients. Shashank Desai, MD, MBA, IHVI’s Director for Strategy and…
Read MoreCardiogenic Shock, ECMO and a Rare Heart-Lung Transplant
Corey Saul started his 20s as a healthy young man. Little did he know, he was kicking off a tumultuous decade. By the time he turned 28, Corey had gotten a surprise genetic diagnosis, survived cardiogenic shock and received a combined heart-lung transplant. Thanks to Inova’s groundbreaking Cardiogenic Shock Team and the multidisciplinary experts at…
Read MoreFace Mask Policy Changes – April 3, 2023
Effective Monday, April 3, masking will be optional at Inova patient care sites. Exceptions will include high-risk clinical spaces and for anyone interacting with patients who are identified by their provider as immunocompromised or at high risk for severe disease from COVID-19. Go Deeper: Team member and patient safety has been and continues to be…
Read MoreInova Congenital Cardiology Program Offers Full Spectrum of Care
For more than 30 years, Inova has provided specialized care to children with congenital heart disease (CHD) through Inova Children’s Heart Center. An adult program launched in 1994 to give pediatric CHD patients a seamless transition to continue under our care. The program provides a medical home with expert care for young adults managing their…
Read MoreSuzuki Receives 2023 AstraZeneca Lung Cancer Research Award
The Board of Directors of The Thoracic Surgery Foundation has named Kei Suzuki, MD, the recipient of the 2023 AstraZeneca Lung Cancer Research Award. Suzuki was recognized for his project, “Single-cell RNA sequence profiling of tumor-immune microenvironment for precision therapy in resectable lung cancer.” “This funding is crucial to take the research to the next…
Read More